Table 4.
World Health Organization Quality of Life-26 scores subdivided according to fasting plasma glucose levels, HbA1c levels, and 75-g oral glucose tolerance test results
| Fasting plasma glucose (mg/dl) | ||||
|---|---|---|---|---|
| <110 (N = 927) | 110–125 (N = 50) | ≥126 (N = 24) | Treated group (N = 51) | |
| Mean ± SD | 90.3 ± 7.8 | 115.8 ± 4.9 | 161.5 ± 46.8 | 128.9 ± 34.8a |
| Total score | 3.44 ± 0.43 | 3.44 ± 0.45 | 3.51 ± 0.60 | 3.25 ± 0.43* |
| HbA1c (%) | ||||
|---|---|---|---|---|
| <5.9 (N = 668) | 5.9–6.4 (N = 278) | ≥6.5 (N = 54) | Treated group (N = 51) | |
| Mean ± SD | 5.53 ± 0.24 | 6.06 ± 0.15 | 7.25 ± 1.33 | 7.29 ± 1.32b |
| Total score | 3.44 ± 0.44 | 3.45 ± 0.40 | 3.46 ± 0.54 | 3.25 ± 0.43* |
| 75 g OGTT | ||||
|---|---|---|---|---|
| Normal (N = 628) | IGT (N = 297) | Diabetes (N = 65) | Treated group (N = 51) | |
| Total score | 3.45 ± 0.42 | 3.41 ± 0.45 | 3.50 ± 0.46 | 3.25 ± 0.43* |
OGTT oral glucose tolerance test, IGT impaired glucose tolerance
* Significant at p < 0.01 by Dunnett’s tests
aFasting plasma glucose (FPG) of the treated group was significant lower than the ≥126 mg/dl in FPG group without treatment
bHbA1c of the treated group was not significantly different from the ≥6.5 % in the HbA1c group without treatment